Parallel Advisors, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Parallel Advisors, LLC

$4.87 Billion
Q2 2025

A detailed history of Parallel Advisors, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 732 shares of RARE stock, worth $20,576. This represents 0.0% of its overall portfolio holdings.

Number of Shares

732

Previous 63 1061.9%

Holding current value

$20,576

Previous $2,000 1200.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 07, 2025	BUY	$31.06 - $39.3 $20,779 - $26,291	669 Added 1061.9%	732 $26,000
Q1 2025 Apr 07, 2025	SELL	$36.21 - $45.78 $5,866 - $7,416	-162 Reduced 72.0%	63 $2,000
Q4 2024 Feb 10, 2025	SELL	$42.07 - $57.72 $12,368 - $16,969	-294 Reduced 56.65%	225 $9,000
Q3 2024 Nov 13, 2024	BUY	$40.21 - $59.36 $12,384 - $18,282	308 Added 145.97%	519 $28,000
Q2 2024 Aug 08, 2024	BUY	$37.42 - $51.61 $5,351 - $7,380	143 Added 210.29%	211 $8,000
Q1 2024 May 06, 2024	BUY	$43.02 - $53.69 $1,591 - $1,986	37 Added 119.35%	68 $3,000
Q4 2023 Feb 09, 2024	SELL	$31.73 - $49.19 $7,551 - $11,707	-238 Reduced 88.48%	31 $1,000
Q3 2023 May 20, 2024	SELL	$34.92 - $46.66 $6,111 - $8,165	-175 Reduced 39.41%	269 $9,000
Q3 2023 Nov 13, 2023	SELL	$34.92 - $46.66 $6,111 - $8,165	-175 Reduced 39.41%	269 $9,000
Q2 2023 May 20, 2024	BUY	$37.35 - $52.15 $11,317 - $15,801	303 Added 214.89%	444 $20,000
Q2 2023 Aug 04, 2023	BUY	$37.35 - $52.15 $11,317 - $15,801	303 Added 214.89%	444 $20,000
Q1 2023 May 20, 2024	BUY	$36.99 - $48.71 $2,700 - $3,555	73 Added 107.35%	141 $5,000
Q1 2023 Apr 25, 2023	SELL	$36.99 - $48.71 $7,176 - $9,449	-194 Reduced 57.91%	141 $5,000
Q4 2022 Feb 03, 2023	BUY	$33.72 - $46.33 $7,452 - $10,238	221 Added 193.86%	335 $15,000
Q3 2022 Nov 10, 2022	BUY	$39.96 - $66.14 $679 - $1,124	17 Added 17.53%	114 $5,000
Q2 2022 Aug 01, 2022	BUY	$45.8 - $85.4 $1,923 - $3,586	42 Added 76.36%	97 $6,000
Q1 2022 Apr 28, 2022	SELL	$62.2 - $84.4 $2,114 - $2,869	-34 Reduced 38.2%	55 $4,000
Q4 2021 Jan 20, 2022	BUY	$73.71 - $87.86 $6,191 - $7,380	84 Added 1680.0%	89 $7,000
Q3 2021 Nov 02, 2021	BUY	$77.92 - $102.4 $389 - $512	5 New	5 $0
Q2 2021 Aug 06, 2021	SELL	$92.19 - $115.71 $645 - $809	-7 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$106.9 - $167.73 $748 - $1,174	7 New	7 $1,000
Q3 2019 Nov 01, 2019	SELL	$42.5 - $63.11 $1,190 - $1,767	-28 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$39.87 - $69.36 $10,764 - $18,727	-270 Reduced 90.6%	28 $2,000
Q4 2018 Feb 05, 2019	BUY	$38.89 - $77.3 $9,800 - $19,479	252 Added 547.83%	298 $12,000
Q4 2017 Feb 13, 2018	BUY	$43.54 - $57.32 $2,002 - $2,636	46	46 $2,000

Others Institutions Holding RARE

# of Institutions

342

Shares Held

90.2M

Call Options Held

1.03M

Put Options Held

1.04M

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $1.97B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Ultragenyx Pharmaceutical Inc. Transaction History